Eisbach Bio Competitors and Similar CompaniesClear all
Eisbach Bio's competitors and similar companies include Aeglea and Olema Oncology.
 Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | |
Founding Date | Founding Date 2019 | Founding Date 2013 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Planegg, DE HQ | Locations Austin, US HQ | Locations San Francisco, US HQ San Francisco, US |
Employees | Employees 118% decrease | Employees 65117% increase | Employees 9630% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) 679.2 m |
Financial | |||
Net income | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income ($162.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company